Meeting notes from the 3rd IAS Conference. HIV treatment and risk for metabolic complications.
New studies describe risk factors for diabetes, the metabolic syndrome, and dyslipidemia in HIV-infected patients.
Currier
Judith
J
D019380:Anti-HIV Agents / Q000378:metabolism*; D001938:Brazil; D003226:Congresses as Topic; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008660:Metabolism / Q000187:drug effects*; D018570:Risk Assessment
D019380:Anti-HIV Agents